Local Excision Techniques for Rectal Cancer After Neoadjuvant Chemoradiotherapy: What Are We Doing?

Dis Colon Rectum

1 Department of Surgery, Royal Liverpool and Broadgreen University Hospitals National Health Service Trust, Liverpool, United Kingdom 2 Epsom and St Helier University Hospitals National Health Service Trust, London, United Kingdom 3 Angelita and Joaquim Gama Institute and School of Medicine, University of São Paulo, São Paulo, Brazil 4 Marks Colorectal Associates, Lankenau Hospital, Philadelphia, Pennsylvania, USA 5 Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland 6 Pelican Cancer Centre, Basingstoke, United Kingdom.

Published: February 2017

Background: Recent evidence shows that the majority of rectal cancers demonstrate occult tumor scatter after neoadjuvant chemoradiotherapy that can extend for several centimeters under adjacent normal-appearing mucosa beside the residual mucosal abnormality or scar.

Objective: This systematic review aimed to determine all of the published selection criteria and technical descriptions for local excision to date with regard to this phenomenon.

Data Sources: PubMed, MEDLINE, and Embase were searched using the following key words: rectal cancer, local excision, radiotherapy, and neoadjuvant.

Study Selection: Studies that assessed local excision of rectal cancer after neoadjuvant chemoradiotherapy were included. Duplicate series were excluded from final analysis.

Intervention: All of the data points were tabulated and analyzed using Microsoft Excel.

Main Outcome Measures: Criteria for patient selection, surgical technique, clinical restaging, pathologic assessment, and indications for completion surgery were analyzed.

Results: After exclusions, data from 25 studies that in total evaluated local excision in 1001 patients were included. Compared with the single accepted technique of total mesorectal excision, described techniques for local excision after neoadjuvant therapy demonstrate significant variability in many critical technical issues, such as marking/tattooing original tumor margins before neoadjuvant therapy, using pretreatment tumor size/stage as exclusion criteria, and specifically stating lateral excision margins. Where detailed, the majority of local recurrences occurred in patients with clear pathological margins, yet significant variation existed for pathological assessment and reporting, with few studies detailing R status and some not reporting margin status at all. Significant variability also existed for adverse tumor features that mandated completion surgery, and, importantly, many series describe patients refusing completion surgery where indicated.

Limitations: We were unable to perform meta-analysis because studies lacked sufficient methodologic homogeneity to synthesize.

Conclusions: The observations from this study prompt additional study, standardization of technique, and cautious use of local excision of rectal cancer in the setting of neoadjuvant chemoradiotherapy.

Download full-text PDF

Source
http://dx.doi.org/10.1097/DCR.0000000000000749DOI Listing

Publication Analysis

Top Keywords

local excision
28
rectal cancer
16
neoadjuvant chemoradiotherapy
16
completion surgery
12
local
8
cancer neoadjuvant
8
excision
8
excision rectal
8
neoadjuvant therapy
8
neoadjuvant
6

Similar Publications

Traumatic aneurysms represent less than 1 percent of intracranial aneurysms and middle meningeal artery pseudoaneurysms are even rare. Traumatic aneurysms are usually pseudoaneurysms formed by the rupture of all the layers of the vessel wall. They are associated with high mortality as they can present as epidural, subdural, and rarely intraparenchymal hematoma.

View Article and Find Full Text PDF

A woman in her early 20s presented with progressive low back pain, leg weakness and sphincter dysfunction. MRI revealed a 5 × 1.5 cm intramedullary tumour at the T12-L2 level.

View Article and Find Full Text PDF

Background: Preoperative chemoradiotherapy combined with total mesorectal excision (TME) is a standard treatment for locally advanced rectal cancer (LARC). However, lateral pelvic lymph nodes (LPLNs) are often inadequately treated with standard regimens. This study examines the treatment and postoperative outcomes in LARC patients receiving a simultaneous integrated boost (SIB) for LPLNs during long-course chemoradiotherapy.

View Article and Find Full Text PDF

Background: The watch-and-wait strategy provides an opportunity to pursue non-operative management in rectal cancer patients with clinical complete response after neoadjuvant therapy. The management of those with near complete response remains controversial.

Objective: We assessed the oncologic outcomes of patients managed by watch-and-wait versus total mesorectal excision according to clinical response to neoadjuvant therapy.

View Article and Find Full Text PDF

Background: Low anterior resection (LAR) is the gold standard for curative cancer treatment in the middle and upper rectum. In radically operated patients, the local recurrence rates with total mesorectal excision (TME) after 5 and 10 years was<10%, with 80% in 5 years survival. Anastomotic leakage (AL) affects 4%-20% of patients who underwent LAR.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!